Nuchal Translucency Evaluation at 11 to 14 Weeks Gestational Age

[1]  M. Kilby,et al.  Early prognostic factors of outcomes in monochorionic twin pregnancy: systematic review and meta‐analysis , 2018, American journal of obstetrics and gynecology.

[2]  M. Shohat,et al.  Cut‐off value of nuchal translucency as indication for chromosomal microarray analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  M. Norton,et al.  Testing for Noonan syndrome after increased nuchal translucency , 2017, Prenatal diagnosis.

[4]  S. Ferrero,et al.  Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis , 2017, Fetal Diagnosis and Therapy.

[5]  R. Quintero,et al.  Early prediction of twin‐to‐twin transfusion syndrome: systematic review and meta‐analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[6]  M. Melchior,et al.  Screening for fetal congenital heart disease , 2017, Canadian Medical Association Journal.

[7]  J. Neilson,et al.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening. , 2017, The Cochrane database of systematic reviews.

[8]  S. Blackwell,et al.  The role of ultrasound in women who undergo cell‐free DNA screening , 2017, American journal of obstetrics and gynecology.

[9]  L. Simpson Practice Bulletin No. 175: Ultrasound in Pregnancy , 2016, Obstetrics and gynecology.

[10]  E. Hayes Practice Bulletin No. 169: Multifetal Gestations Twin, Triplet, and Higher-Order Multifetal Pregnancies , 2016, Obstetrics and gynecology.

[11]  Practice Bulletin No. 162 Summary: Prenatal Diagnostic Testing for Genetic Disorders , 2016, Obstetrics and gynecology.

[12]  Practice Bulletin No. 163 Summary: Screening for Fetal Aneuploidy , 2016, Obstetrics and gynecology.

[13]  Qiao-ling Feng,et al.  Fetal echocardiography for congenital heart disease diagnosis: a meta-analysis, power analysis and missing data analysis , 2015, European journal of preventive cardiology.

[14]  Y. Blumenfeld,et al.  Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[15]  T. van Mieghem,et al.  Early fetal anatomy screening: who, what, when and why? , 2015, Current opinion in obstetrics & gynecology.

[16]  M. D'Alton,et al.  Nuchal Translucency Quality Review (NTQR) program: first one and half million results , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[17]  C. Bilardo,et al.  Early detection of fetal cardiac abnormalities: how effective is it and how should we manage these patients? , 2014, Prenatal diagnosis.

[18]  C. Comas,et al.  Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta‐analysis , 2014, Prenatal diagnosis.

[19]  H. Cuckle,et al.  Nuchal translucency in twins according to mode of assisted conception and chorionicity , 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[20]  F. Prefumo,et al.  Accuracy of Ultrasonography at 11–14 Weeks of Gestation for Detection of Fetal Structural Anomalies: A Systematic Review , 2013, Obstetrics and gynecology.

[21]  L. Simpson Ultrasound in twins: dichorionic and monochorionic. , 2013, Seminars in perinatology.

[22]  K. Nicolaides,et al.  Fetal heart defects: potential and pitfalls of first-trimester detection. , 2013, Seminars in fetal & neonatal medicine.

[23]  E. Kanal,et al.  ACR guidance document on MR safe practices: 2013 , 2013, Journal of magnetic resonance imaging : JMRI.

[24]  K. Nicolaides,et al.  Contribution of Fetal Tricuspid Regurgitation in First-Trimester Screening for Major Cardiac Defects , 2011, Obstetrics and gynecology.

[25]  Kypros H Nicolaides,et al.  Screening for fetal aneuploidies at 11 to 13 weeks , 2011, Prenatal diagnosis.

[26]  K. Nicolaides,et al.  Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks , 2011, Prenatal diagnosis.

[27]  Rvt,et al.  AIUM Practice Guideline for the Performance of Fetal Echocardiography , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[28]  K. Nicolaides,et al.  Additional first-trimester ultrasound markers. , 2010, Clinics in laboratory medicine.

[29]  K. Nicolaides,et al.  Ductus Venosus in the First Trimester: Contribution to Screening of Chromosomal, Cardiac Defects and Monochorionic Twin Complications , 2010, Fetal Diagnosis and Therapy.

[30]  N. Montenegro,et al.  Screening for twin–twin transfusion syndrome at 11–14 weeks of pregnancy: the key role of ductus venosus blood flow assessment , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[31]  E. Gratacós,et al.  Prevalence and perinatal outcome of dichorionic and monochorionic twins with nuchal translucency above the 99th percentile and normal karyotype , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[32]  K. Kagan,et al.  Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[33]  I. Staboulidou,et al.  Ductus Venosus Doppler at 11 to 13 Weeks of Gestation in the Prediction of Outcome in Twin Pregnancies , 2009, Obstetrics and gynecology.

[34]  K. Kagan,et al.  Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[35]  F. Malone,et al.  Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[36]  I. Timor-Tritsch,et al.  Performing a Fetal Anatomy Scan at the Time of First-Trimester Screening , 2009, Obstetrics and gynecology.

[37]  K. Kagan,et al.  Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[38]  P. Lewi,et al.  The role of ultrasound examination in the first trimester and at 16 weeks' gestation to predict fetal complications in monochorionic diamniotic twin pregnancies. , 2008, American journal of obstetrics and gynecology.

[39]  T. Crombleholme,et al.  Initial fetal cardiovascular profile score predicts recipient twin outcome in twin-twin transfusion syndrome. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[40]  K. Kagan,et al.  Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[41]  K. Nicolaides,et al.  Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[42]  A. Rebarber,et al.  First-trimester screening with nasal bone in twins. , 2007, American journal of obstetrics and gynecology.

[43]  J. Hyett,et al.  Nuchal translucency and the risk of congenital heart disease. , 2007, Obstetrics and gynecology.

[44]  K. Kagan,et al.  Discordance in nuchal translucency thickness in the prediction of severe twin‐to‐twin transfusion syndrome , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[45]  F. Malone,et al.  Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? , 2006, American journal of obstetrics and gynecology.

[46]  R. Berkowitz,et al.  First trimester screening for Down syndrome in multiple pregnancy. , 2005, Seminars in perinatology.

[47]  A. Rudnicka,et al.  First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, The New England journal of medicine.

[48]  F. Malone,et al.  First-Trimester Septated Cystic Hygroma: Prevalence, Natural History, and Pediatric Outcome , 2005, Obstetrics and gynecology.

[49]  K. Nicolaides,et al.  Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[50]  I. Blickstein,et al.  Down syndrome screening in multiple pregnancies. , 2005, Obstetrics and gynecology clinics of North America.

[51]  J. Ioannidis,et al.  Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. , 2003, American journal of obstetrics and gynecology.

[52]  F. Malone,et al.  First‐Trimester Sonographic Screening for Down Syndrome , 2003, Obstetrics and gynecology.

[53]  R. Quintero,et al.  Twin-twin transfusion syndrome. , 2003, Clinics in perinatology.

[54]  W. Giles,et al.  The Doppler Assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery Doppler ultrasound and biometry in twin pregnancy , 2003, BJOG : an international journal of obstetrics and gynaecology.

[55]  K. Nicolaides,et al.  Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years experience , 2003, BJOG : an international journal of obstetrics and gynaecology.

[56]  M. Haak,et al.  Echocardiography in Early Pregnancy , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[57]  S. Cicero,et al.  Increased fetal nuchal translucency at 11–14 weeks , 2002, Prenatal diagnosis.

[58]  S. Cicero,et al.  Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11–14 weeks of gestation , 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[59]  K. Hecher,et al.  Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[60]  K. Nicolaides,et al.  Early prediction of severe twin-to-twin transfusion syndrome. , 2000, Human reproduction.

[61]  K. Nicolaides,et al.  UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation , 1998, The Lancet.

[62]  K. Nicolaides,et al.  Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation , 1996, British journal of obstetrics and gynaecology.

[63]  D. Economides,et al.  The measurement of nuchal translucency with transabdominal and transvaginal sonography--success rates, repeatability and levels of agreement. , 1995, The British journal of radiology.

[64]  K. Nicolaides,et al.  First‐Trimester Fetal Nuchal Translucency Thickness and Risk for Trisomies , 1994, Obstetrics and gynecology.

[65]  K. Nicolaides,et al.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. , 1992, BMJ.

[66]  I. Thaler,et al.  FIRST TRIMESTER TRANSVAGINAL SONOGRAPHIC DIAGNOSIS OF FETAL ANOMALIES , 1989, The Lancet.

[67]  PARAMETER FOR IMAGING PREGNANT OR POTENTIALLY PREGNANT ADOLESCENTS AND WOMEN WITH IONIZING RADIATION , 2016 .

[68]  F. Mri ACR-SPR PRACTICE PARAMETER FOR THE SAFE AND OPTIMAL PERFORMANCE OF FETAL MAGNETIC RESONANCE IMAGING (MRI) , 2014 .

[69]  F. Walther,et al.  Congenital heart disease in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. , 2007, Congenital heart disease.

[70]  A. Nadel First-trimester nasal bone evaluation for aneuploidy in the general population. , 2005, Obstetrics and gynecology.

[71]  S. Cox,et al.  Society for Maternal-Fetal Medicine , 1999 .

[72]  K. Nicolaides,et al.  Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency , 1995, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.